234 related articles for article (PubMed ID: 26321136)
1. A possible difference in the mechanism for postprandial hypoglycemia associated with dumping syndrome between patients with and without type 2 diabetes.
Hamasaki H; Moriyama S; Yanai H
Obes Res Clin Pract; 2015; 9(6):622-4. PubMed ID: 26321136
[TBL] [Abstract][Full Text] [Related]
2. Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy.
Miholic J; Orskov C; Holst JJ; Kotzerke J; Meyer HJ
Dig Dis Sci; 1991 Oct; 36(10):1361-70. PubMed ID: 1914756
[TBL] [Abstract][Full Text] [Related]
3. Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia.
Toft-Nielsen M; Madsbad S; Holst JJ
Diabetologia; 1998 Oct; 41(10):1180-6. PubMed ID: 9794105
[TBL] [Abstract][Full Text] [Related]
4. Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome.
Gebhard B; Holst JJ; Biegelmayer C; Miholic J
Dig Dis Sci; 2001 Sep; 46(9):1915-23. PubMed ID: 11575444
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of beinaglutide in a patient with late dumping syndrome after gastrectomy: A case report.
Ding B; Hu Y; Yuan L; Yan RN; Ma JH
Medicine (Baltimore); 2021 May; 100(21):e26086. PubMed ID: 34032745
[TBL] [Abstract][Full Text] [Related]
6. Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia.
Craig CM; Liu LF; Deacon CF; Holst JJ; McLaughlin TL
Diabetologia; 2017 Mar; 60(3):531-540. PubMed ID: 27975209
[TBL] [Abstract][Full Text] [Related]
7. Acarbose improves hypoglycaemia following gastric bypass surgery without increasing glucagon-like peptide 1 levels.
Valderas JP; Ahuad J; Rubio L; Escalona M; Pollak F; Maiz A
Obes Surg; 2012 Apr; 22(4):582-6. PubMed ID: 22161170
[TBL] [Abstract][Full Text] [Related]
8. Hypoglycemia unawareness in a patient with dumping syndrome: report of a case.
Bellini F; Sammicheli L; Ianni L; Pupilli C; Serio M; Mannelli M
J Endocrinol Invest; 1998; 21(7):463-7. PubMed ID: 9766263
[TBL] [Abstract][Full Text] [Related]
9. The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes.
Lund A; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1038-46. PubMed ID: 21386059
[TBL] [Abstract][Full Text] [Related]
10. [Postalimentary hypoglycaemia in post-gastrectomy late dumping syndrome].
Thalhammer M; Cuk A; Palitzsch KD
Dtsch Med Wochenschr; 2005 Feb; 130(8):393-6. PubMed ID: 15717249
[TBL] [Abstract][Full Text] [Related]
11. [Studies on the relation between late dumping syndrome and glucagon responses to glucose].
Matsui T
Nihon Heikatsukin Gakkai Zasshi; 1988 Jun; 24(3):159-70. PubMed ID: 3073247
[TBL] [Abstract][Full Text] [Related]
12. Octreotide improves early dumping syndrome potentially through incretins: a case report.
Sato D; Morino K; Ohashi N; Ueda E; Ikeda K; Yamamoto H; Ugi S; Yamamoto H; Araki S; Maegawa H
Endocr J; 2013; 60(7):847-53. PubMed ID: 23708181
[TBL] [Abstract][Full Text] [Related]
13. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
[TBL] [Abstract][Full Text] [Related]
14. A possible role of GLP-1 in the pathophysiology of early dumping syndrome.
Yamamoto H; Mori T; Tsuchihashi H; Akabori H; Naito H; Tani T
Dig Dis Sci; 2005 Dec; 50(12):2263-7. PubMed ID: 16416173
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of surgical control of type 2 diabetes: GLP-1 is the key factor-Maybe.
Salehi M; D'Alessio DA
Surg Obes Relat Dis; 2016 Jul; 12(6):1230-5. PubMed ID: 27568473
[TBL] [Abstract][Full Text] [Related]
16. Improvement of dumping syndrome and oversecretion of glucose-dependent insulinotropic polypeptide following a switch from olanzapine to quetiapine in a patient with schizophrenia.
Watanabe A; Fukui N; Suzuki Y; Motegi T; Igeta H; Tsuneyama N; Someya T
Gen Hosp Psychiatry; 2015; 37(4):372.e5-6. PubMed ID: 25835510
[TBL] [Abstract][Full Text] [Related]
17. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
[TBL] [Abstract][Full Text] [Related]
18. Long-term effect of alpha-glucosidase inhibitor on late dumping syndrome.
Hasegawa T; Yoneda M; Nakamura K; Ohnishi K; Harada H; Kyouda T; Yoshida Y; Makino I
J Gastroenterol Hepatol; 1998 Dec; 13(12):1201-6. PubMed ID: 9918426
[TBL] [Abstract][Full Text] [Related]
19. Teneligliptin improves glycemic control with the reduction of postprandial insulin requirement in Japanese diabetic patients.
Tsuchimochi W; Ueno H; Yamashita E; Tsubouchi C; Sakoda H; Nakamura S; Nakazato M
Endocr J; 2015; 62(1):13-20. PubMed ID: 25252844
[TBL] [Abstract][Full Text] [Related]
20. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
Østoft SH
Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
